Merck
  • Home
  • Search Results
  • Effect of melatonin and analogues on corneal wound healing: involvement of Mt2 melatonin receptor.

Effect of melatonin and analogues on corneal wound healing: involvement of Mt2 melatonin receptor.

Current eye research (2014-06-04)
Almudena Crooke, Ana Guzman-Aranguez, Aranzazu Mediero, Pilar Alarma-Estrany, Gonzalo Carracedo, Teresa Pelaez, Assumpta Peral, Jesús Pintor
ABSTRACT

We have investigated the effect of melatonin and its analogues on rabbit corneal epithelial wound healing. New Zealand rabbits were anaesthetised and wounds were made by placing Whatman paper discs soaked in n-heptanol on the cornea. Melatonin and analogues (all 10 nmol) were instilled. Wound diameter was measured every 2 hours by means of fluorescein application with a Topcon SL-8Z slit lamp. Melatonin antagonists (all 10 nmol) were applied 2 hours before the application of the n-heptanol-soaked disc and then every 6 hours together with melatonin. To confirm the presence of MT2 receptors in corneal epithelial cells immunohistochemistry, Western blot and RT-PCR assays in native tissue and in rabbit corneal epithelial cells were performed. The tear components were extracted then processed by HPLC to quantify melatonin in tears. Migration assays revealed that melatonin and particularly the treatment with the MT2 agonist IIK7, accelerated the rate of healing (p < 0.001). The application of the non-selective melatonin receptor antagonist luzindole and the MT2 antagonist DH97 (but not prazosin), prevented the effect of melatonin on wound healing (both p < 0.001). Immunohistochemistry, Western blot and RT-PCR assays showed the presence of MT2 melatonin receptor in corneal epithelial cells. In addition, we have identified melatonin in tears and determined its daily variations. These data suggest that MT2 receptors are implicated in the effect of melatonin on corneal wound healing regulating migration rate. This suggests the potential use of melatonin and its analogues to enhance epithelial wound healing in ocular surface disease.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
塩化ナトリウム, BioXtra, ≥99.5% (AT)
Sigma-Aldrich
塩化マグネシウム 溶液, for molecular biology, 1.00 M±0.01 M
Sigma-Aldrich
塩化ナトリウム, for molecular biology, DNase, RNase, and protease, none detected, ≥99% (titration)
Sigma-Aldrich
塩化ナトリウム 溶液, 5 M in H2O, BioReagent, for molecular biology, suitable for cell culture
Sigma-Aldrich
塩化マグネシウム, anhydrous, ≥98%
Sigma-Aldrich
塩化ナトリウム, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture, ≥99%
Sigma-Aldrich
フェニルメチルスルホニルフルオリド, ≥98.5% (GC)
Sigma-Aldrich
塩化ナトリウム 溶液, 0.9% in water, BioXtra, suitable for cell culture
Sigma-Aldrich
L-グルタミン, meets USP testing specifications, suitable for cell culture, 99.0-101.0%, from non-animal source
Sigma-Aldrich
メラトニン, powder, ≥98% (TLC)
Sigma-Aldrich
塩化ナトリウム 溶液, 5 M
Sigma-Aldrich
フッ化ナトリウム, ACS reagent, ≥99%
Sigma-Aldrich
L-グルタミン, ReagentPlus®, ≥99% (HPLC)
SAFC
L-グルタミン
Sigma-Aldrich
塩化ナトリウム, meets analytical specification of Ph. Eur., BP, USP, 99.0-100.5%
Sigma-Aldrich
塩化マグネシウム 溶液, BioUltra, for molecular biology, ~1 M in H2O
Sigma-Aldrich
塩化ナトリウム, JIS special grade, ≥99.5%
Sigma-Aldrich
塩化ナトリウム, BioUltra, for molecular biology, ≥99.5% (AT)
Sigma-Aldrich
塩化マグネシウム, powder, <200 μm
Supelco
塩化ナトリウム, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
フェニルメチルスルホニルフルオリド, ≥99.0% (T)
USP
メラトニン, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
塩化ナトリウム 溶液, 0.85%
Sigma-Aldrich
塩化ナトリウム 溶液, BioUltra, for molecular biology, ~5 M in H2O
Sigma-Aldrich
塩化マグネシウム 溶液, BioUltra, for molecular biology, 2 M in H2O
Sigma-Aldrich
フッ化ナトリウム, BioXtra, ≥99%
Supelco
フッ化ナトリウム, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
塩化ナトリウム, certified reference material for titrimetry, certified by BAM, ≥99.5%
Supelco
Fluoride ion solution for ISE, 0.1 M F-, analytical standard (for ion-selective electrodes)
Sigma-Aldrich
塩化ナトリウム, 99.999% trace metals basis